SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Return on Tangible Assets Over TimeExpanding
Percentile Rank83
5Y CAGR-26.4%
Studio
Year-over-Year Change

Return on tangible assets

5Y CAGR
-26.4%/yr
Long-term compound
Percentile
P83
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
20257.68%+110.0%
2024-77.17%-53.5%
2023-50.27%-36.5%
2022-36.82%-74.2%
2021-21.13%-159.4%
202035.58%+171.3%
2019-49.91%-